A healthcare professional gives you the solution by injection into a vein (called an intravenous ... See the dosage table in the “Briumvi dosage for certain forms of MS” section, which ...
The prescribed dosage for Genotropin (somatropin) may depend on your condition and your treatment plan. Doctors may base some dosages of the drug on body weight. Genotropin (somatropin ...
However, some practitioners have been lulled into a false sense of security, allowing the drug's good safety ... would leave the propofol syringe and needle in the IV port after placing the ...
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.
The updated label allows physicians to prescribe Izervay without a limitation on duration for patients with geographic ...
The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...
Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.
Purpose: The frequency of drug administration errors and incompatibilities between intravenous drugs before and after an intervention in an intensive care unit (ICU) is discussed. Methods ...
Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...
Data show Anaphylm maintains consistent stability and potency under extreme temperature and real-world conditions, including heat, freezing, and ...
Apellis is expecting decisions on the drug form regulators in the UK, Switzerland, Canada, and Australia early next year. At JP Morgan last month, pharmaphorum caught up with Paul Hastings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback